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ABSTRACT  We have produced and characterized monoclonal antibodies that label antigenic 
determinants distributed  among three distinct, nonoverlapping  peptide domains of the 200- 
kD  heavy chain  of avian smooth  muscle myosin. Mice  were  immunized  with  a  partially 
phosphorylated  chymotryptic digest of adult  turkey  gizzard myosin. Hybridoma  antibody 
specificities were determined  by solid-phase indirect  radioimmunoassay and immunoreplica 
techniques.  Electron microscopy of rotary-shadowed samples was used to directly  visualize 
the topography of individual  [antibody. antigen] complexes. 
Antibody TGM-1 bound to a 50-kD peptide of subfragment-1 (S-1) previously found to be 
associated with actin binding and was localized by immunoelectron  microscopy to the distal 
aspect of the  myosin head. However,  there  was  no antibody-dependent inhibition  of the 
actin-activated  heavy meromyosin ATPase, nor was  antibody TGM-1 binding  to actin-S-1 
complexes inhibited. Antibody TGM-2 detected an epitope of the subfragment-2 (S-2) domain 
of  heavy  meromyosin  but  not  the  S-2  domain  of  intact  myosin or  rod,  consistent  with 
recognition of a site exposed by chymotryptic cleavage of the S-2:light meromyosin junction. 
Localization of TGM-2 to the carboxy-terminus of S-2 was substantiated by immunoelectron 
microscopy. Antibody TGM-3 recognized an epitope  found  in the light meromyosin portion 
of myosin. All three antibodies were specific for avian smooth muscle myosin. Of particular 
interest  is  that  antibody  TGM-1,  unlike  TGM-3,  bound  poorly  to  homogenates of  19-d 
embryonic  smooth  muscles. This indicates the expression of different  myosin heavy chain 
epitopes during smooth muscle development. 
The structural organization of myosin molecules is conserved 
throughout evolution and among myosins of disparate tissue 
origin. A  pair of heavy chains comprises both carboxy-ter- 
minal  a-helical domains that form a  coiled-coil "tail" and 
amino-terminal  domains  that  form  two  globular  "heads." 
Each head is  associated with a  regulatory and an essential 
light  chain.  Interaction of myosin  heads  with  filamentous 
actin, activation by actin of the Mg2+-ATPase of the myosin 
molecule, and functional coupling between ATP hydrolysis 
and force generation are essential and ubiquitous processes 
for contraction and other motile events in muscle and non- 
muscle cells (1). In vertebrate striated muscles, myosin poly- 
morphism is apparent not only for light chains characteristic 
of specific  muscle  classes,  fiber types,  and  developmental 
stages (2-4), but also for myosin heavy chains of skeletal (5- 
9) and cardiac (10-12) muscle myosin. In contrast, the struc- 
tural and functional organization and development of myosin 
in  vertebrate smooth  muscle  have  received relatively little 
study. We have produced a series of monoclonal antibodies 
(mAb) ~ directed against antigenic determinants (epitopes) of 
smooth muscle myosin, as probes for such investigations. 
We report here results obtained with hybridoma antibodies 
that recognize three distinct nonoverlapping domains of the 
heavy chain of avian smooth muscle myosin: heavy mero- 
myosin (HMM)  subfragment-I  (S-l),  subfragment-2  (S-2), 
~Abbreviations used in this paper.  HMM, heavy meromyosin; ~251- 
F(ab')2, ~251-1abeled F(ab')2 fragment of affinity-purified sheep lgG 
directed against mouse immunoglobulins; LCIT, 17-kD myosin light 
chain; LC20, 20-kD  myosin light chain; LMM, light meromyosin; 
mAb, monoclonal antibody; 32P-LC2o, LC2o radiophosphorylated  by 
myosin light chain kinase; S-l,  HMM subfragment-1; S-2, HMM 
subfragment-2. 
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aspects of smooth muscle myosin by assaying for antibody- 
dependent effects on the actin-activated HMM Mg2*-ATPase 
and for actin-dependent effects on mAb binding.  We have 
investigated the structure of  the smooth muscle myosin heavy 
chain, not only with its purified peptide domains, immuno- 
blot techniques, and electron microscopy of rotary-shadowed 
[antibody.antigen] complexes, but also in conjunction with 
radiophosphorylated myosin light  chains  (13)  as  a  unique 
structural probe. 
MATERIALS  AND  METHODS 
Materials:  Nitrocellulose  filtration  plates  (pore  size  0.45 pm,  type 
STHA) were purchased from Millipore Corp. (Bedford, MA), and nitrocellulose 
membranes (pore size 0.20 #m, type BA83) from Schleicher and Scheull, Inc. 
(Keene, NH).  t2~l-labeled F(ab')2 fragment  of affinity-purified sheep IgG di- 
rected against  mouse immunoglobulins [~251-F(ab')2, 8.5  x  105 Ci/mol] was 
purchased  from New England  Nuclear  (Boston,  MA). Reagents  for sodium 
dodecyl sulfate (NaDodSO4)-polyacrylamide gel electrophoresis (SDS PAGE) 
were obtained  from Bio-Rad Laboratories (Richmond,  CA). Trypsin (3x crys- 
tallized, type TRL3), chymotrypsin (3x crystallized, type CDI), and papain (2x 
crystallized, type  PAP) were obtained  from Worthington  Biochemical Corp. 
(Freehold,  N  J).  Initial  stocks  of P3-X63.Ag8  murine  myeloma cells were 
obtained from Dr. Marshall Nirenberg (National Institutes of Health). 
Production of Monoclonal Antibodies:  To  prepare smooth 
muscle  myosin  as  immunogen and  as  antigen  for  initial  screening  assays, 
myosin  was purified  from adult  turkey  gizzards (14). Gizzard  myosin  was 
phosphorylated by myosin light chain kinase (14) to ~0.5 mol PO4/mol 20-kD 
myosin  light chain  (LC2o) and subsequently  subjected  to limited  proteolysis 
with chymotrypsin  (1  mg/100 mg myosin) at 25"C in 500 mM NaCI, 10 mM 
MgC12, 50 mM Tris-HCI, pH 7.4. The reaction was stopped after  10 rain with 
the  addition  of phenylmethylsulfonyl  fluoride to 0.5  mM.  Female  6-wk-old 
BALB/c  mice were inoculated  intraperitoneally  at 0 and  8 d  with  75  #g of 
myosin chymotryptic  digest in complete  Freund's adjuvant,  and at  15 d with 
75 ug of myosin digest intraveneously  without  adjuvant.  Cell fusion at  18  d 
and  subsequent  derivation  of hybridoma  cell lines  (15) were as previously 
described ( 16,  17). 
Solid-Phase Indirect Radioimmunoassay:  Myosin chymotryp- 
tic digest (10 #g in 2 #l per well of 0.5 M NaCl, 50 mM HEPES, pH 7.5) was 
immunobilized  by evaporation  onto  96-well nitrocellulose  filtration  plates, 
reacted sequentially  with  50 #l/well  of hybridoma-conditioned  medium and 
with 4 nM  ~251-F(ab')2. Bound radioactivity  was determined  by gamma-spec- 
trometry.  Hybridoma-conditioned  media and  t2~I-F(ab')2 solutions were cen- 
trifuged immediately  before use (11,600 g for 60  min and  178,000 g for  l0 
min, respectively), which substantially reduced background variance attributed 
to nonspecifically bound IgG. All results shown [fmol ~251-F(ab')2 specifically 
bound per well] are corrected both for hybridoma  antibody  bound to immo- 
bilized bovine serum albumin (BSA)  and for nonspecifically bound P3-X63.Ag8 
IgG [typically I-1.5% of total 1251-F(ab')2]. Replicates varied by <5%. 
Preparation of Tissue Homogenates:  Embryonated  White Leg- 
horn  chick  eggs were  obtained  from  Truslow  Farms (Chestertown,  MD). 
Portions of 19-d embryonic chick organs were homogenized at 4"C in 5 vol of 
40 mM NaCL l0 mM HEPES. pH 7.5, I mM MgCI2, 5 mM EDTA,  1 mM 
NAN3,  l  mM  dithiothreitol,  l  mM  phenylmethylsulfonyl  fluoride,  l0  #M 
leupeptin, with  12 strokes of a motor-driven  Potter-EIvehjem homogenizer at 
the highest setting (Model 5VB-C, Eastern Mixers, Inc., Clinton, CT), adjusted 
to 0.5 M NaCl, and protein concentration  determined  (18). 
Preparation  of Proteins:  HMM  and  LMM  were  produced  from 
phosphorylated  myosin  by limited  proteolysis with chymotrypsin  (l  mg/100 
mg myosin) in the presence of ATP and terminated  by the addition of 0.5 mM 
phenylmethylsulfonyl fluoride. HMM then was purified as described by Sellers 
et al. (19). whereas LMM was purified essentially as described by Margossian 
and Lowey (20). S-I  and rod  were produced  by limited  digestion of myosin 
with papain (0.01 U/rag myosin) and were then purified as described by Greene 
et al. (21) and Margossian and Lowey (20), respectively. S-2 was produced by 
chymotryptic digestion of myosin rod and purified by the method of  Margossian 
and  Lowey (20)  with  the  inclusion  of low  ionic  strength,  10  mM  MgCI2 
precipitation of contaminating  LMM by centfifugation at 40,000 g for 20 min. 
LCzo and the  17-kD (LC~7) light chains of gizzard myosin were isolated (13), 
and LC2o was radiophosphorylated  as described (14). Actin was purified from 
rabbit skeletal muscle by the method of Spudich and Watt (22) as modified by 
Eisenberg and  Kielley (23). Protein  concentrations  of myosin  subfragments 
were calculated  from  absorbance  measurements  at 280  nm using extinction 
coefficients reported  by  Margossian  and  Lowey (20). Monoclonal  lgG  was 
purified by precipitation  in  70%  (NH4)2SO4 followed by ion-exchange chro- 
matography on DEAE-cellulose as described by Parham  (24) and was homo- 
geneous by SDS PAGE. 
Western Blots:  Peptides were resolved by SDS PAGE, performed as 
described by  Laemmli  (25) or as modified  by Matsudaira  and  Burgess (26). 
Electrophoretic transfer of peptides to nitrocellulose was performed according 
to Towbin et al. (27) at  l0 V for 16 h at 4"C in 25  mM Tris-HCl,  192  mM 
glycine. 20%  methanol  (pH  7.5). Polypeptides  of tissue  homogenates  were 
transferred  in  the  presence  of 0.1% SDS to ensure transfer  of the  200-kD 
myosin heavy chain. Each nitrocellulose replica was reacted sequentially for 2 
h at 4"C with hybridoma-conditioned  medium or purified monoclonal  IgG (5 
pg/ml) and with 0.2  nM  ~2~l-F(ab')2. The distribution  of specifically bound 
monoclonal  lgG  was determined  by  autoradiography  at  -70"C  employing 
Kodak X-Omat AR film and  X-Omatic  fine intensifying screens. No binding 
of ~2Sl-F(ab')2 to peptides of purified myosin fragments or of  tissue homogenates 
was detected  in  the  presence  of equivalent  concentrations  of parental  P3- 
X63.Ag8 myeloma lgG or normal  mouse lgG. 
Low-angle  Platinum Shadowing  of  [mAb. HMM] Com- 
plexes:  Adult  turkey  gizzard  myosin  or HMM  at  120  pg/ml in 0.5  M 
ammonium acetate was incubated with 150 pg/ml of DE52-purified monoclo- 
nal IgG for  16 h at 4"C, and diluted to 60 ug/ml of antigen in 50% glycerol 
immediately  before  spraying  onto  freshly  cleaved mica.  Low-angle  rotary 
shadowing with platinum  and subsequent carbon-coating of metal replicas was 
performed  in  a  Balzers vacuum evaporator  (Balzers,  Hudson,  NH) by  the 
method  of Tyler and Branton  (28). A Zeiss EM-10 electron  microscope (Carl 
Zeiss, Inc.. Thornwood,  NY) was employed at 60-kV accelerating voltage. 
RESULTS 
Specificity for Avian Smooth Muscle Myosin: 
Purified Myosins 
63 of 173 hybridoma colonies assayed  14-24 d  after cell 
fusion produced detectable antibody directed against a chy- 
motryptic digest of partially phosphorylated adult turkey giz- 
zard myosin. We report results obtained with three hybridoma 
cell  lines,  each recloned three times at limiting dilution to 
ensure homogeneity and adapted to growth in roller bottles 
yielding ~ 150 mg/liter of monoclonal immunoglobulin. The 
binding specificity of each mAb was first determined in the 
presence of 10-9-10 -5 g/well of myosin purified from adult 
turkey gizzard, chicken pectoralis, or calf aorta (Fig.  1). An- 
tibodies TGM-I  and TGM-3, under the conditions shown, 
recognized intact turkey gizzard  myosin but  neither avian 
skeletal  muscle  myosin  nor  mammalian  smooth  muscle 
myosin. Antibody was comparably bound to myosin purified 
from gizzards  of adult turkey versus adult chicken (data not 
shown),  mAb TGM-2, which  recognized an  epitope of di- 
gested gizzard myosin in the screening assay, did not, however, 
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FIGURE  I  Specificity  of  mAbs  for avian  smooth  muscle  myosin. 
Myosin purified from adult turkey gizzard (o), chick pectoralis (u), or 
calf aorta (,x) was immobilized by evaporation onto 9g-well nitro- 
cellulose  plates  (10-9-10 -5  g/well)  and  reacted  with  hybridoma 
antibodies by indirect radioimmunoassay. Results  [fmol ~2SI-F(ab')2 
specifically  bound  per well], corrected  as discussed  in  Materials 
and Methods, are shown for three monoclonal antibodies that bind 
the chymotryptic gizzard myosin digest used as immunogen: {A) 
TGM-1, (/3) TGM-2, and (C) TGM-3. 
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19-Day Chick  Embryo 
12  Tissue  HO~A  ogenates 
bind to intact myosin. None of the antibodies tested bound 
to  rabbit  skeletal  muscle  HMM  or  to  nonmuscle  myosin 
purified from chicken intestinal brush border. 
Tissue Homogenates 
To determine the tissue specificity of epitopes recognized 
by antibodies TGM-1 and TGM-3, SDS-denatured homoge- 
nares of 19-d chicken embryo  tissues were analyzed by indirect 
radioimmunoassay (Fig.  2). Antibody TGM-3 bound to ho- 
mogenates of 19-d  embryonic chicken gizzard,  aorta,  and 
intestine, but not to cardiac ventricle, pectoralis, or cerebel- 
lum. The binding of mAb TGM-3 was specific for the 200- 
kD smooth muscle myosin heavy chain as demonstrated in 
the accompanying Western blot (Fig.  3).  In contrast, using 
antibody TMG- 1, little binding to myosin in homogenates of 
19-d  embryonic  chicken  smooth  muscle  was  detected  by 
indirect  radioimmunassay  (Fig.  2).  Results  demonstrating 
binding of each antibody in  the presence of purified adult 
turkey gizzard myosin are included for comparison.  Thus, 
antibody TGM-1  may identify a  region of smooth muscle 
myosin that undergoes developmental regulation and is pref- 
erentially expressed  in  the  adult.  None  of the  antibodies 
bound SDS-denatured homogenates of uterus, stomach, car- 
diac ventricle, pectoralis, cerebellum, or spleen of adult rat 
(data  not  shown),  indicating  specificity for  avian  smooth 
muscle myosin. 
Subfragments of Smooth  Muscle Myosin 
Heavy Chain 
Binding of each antibody was determined in the presence 
of purified intact adult turkey gizzard myosin or its purified 
subunits by indirect radioimmunoassay (Fig. 4) and by West- 
ern  blot  (Fig.  5).  mAb  TGM-I  identified  intact  myosin, 
HMM,  and S-l, but not S-2,  rod, or LMM.  mAb TGM-3 
recognized intact myosin, rod, and LMM, but not HMM, S- 
1, or S-2. Thus, the TGM-1 epitope was localized to S-l, and 
the TGM-3 epitope to LMM. 
mAb TGM-2, which did not bind to intact myosin, bound 
to HMM and S-2 but not S-1, indicating that a free carboxy- 
terminus of S-2 must be present for recognition. To confirm 
this localization of the TGM-2 binding site,  HMM was di- 
gested with papain, and myosin rod was digested with chy- 
motrypsin (Fig.  6,  A  and  E).  The resultant peptides  were 
analyzed by Western blot. mAb TGM-2 bound to undigested 
HMM, to a  number of intermediate fragments, and to S-2 
produced in  a  time-dependent manner  from the carboxy- 
terminus of HMM (Fig.  6 C). Whereas no binding to undi- 
gested rod or its intermediate fragments was detected, mAb 
TGM-2 did bind to S-2 cleaved from the amino-terminus of 
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FIGURE 2  Specificity of mAbs  for embryonic chick smooth  mus- 
cles.  SDS-solubilized  homogenates  of  19-d  embryonic chick giz- 
zard,  aorta,  intestine,  cadiac  ventricle,  pectoralis,  or  cerebellum 
were  characterized  by  indirect  radioimmunoassay  (10  #g  tissue 
protein or purified adult turkey gizzard myosin per welt) as above, 
using mAb TGM-1  (I) or TGM-3  (B). Results shown are  fmol  ~2Sl- 
F(ab'b specifically bound per well. 
FIGURE 3  Identification of smooth muscle  myosin heavy chain in 
tissue homogenates.  Samples (10 #g tissue protein or 3 #g purified 
myosin per lane) were subjected to SDS PAGE (5-20% acrylamide 
gradient):  Lanes: (I)  adult  turkey  gizzard  myosin,  (2)  embryonic 
chick gizzard  myosin,  (3) embryonic chick gizzard,  (4) embryonic 
chick intestine, and (5) embryonic chick pectoralis.  Panel A shows 
the Coomassie  Blue-stained gel; panel  B is an autoradiogram  of a 
nitrocellulose replica reacted sequentially with 5 pg/ml of monoclo- 
nal TGM-3 IgG and with 0.2 nM 12SI-F(ab')2. 
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FIGURE 4  Specificity of mAbs for identified 
domains  of  smooth  muscle  myosin  heavy 
chain by indirect radioimmunoassay.  Adult 
turkey gizzard  myosin and its purified pro- 
teolytic subunits were analyzed by indirect 
radioimmunoassay  (lO-T°-lO  -s g/well) using 
mAbs TGM-1 (A), TGM-2 (B), or TGM-3 (C). 
Results shown are  fmol  ~2SI-F(ab')2 specifi- 
cally bound per well. The symbols are iden- 
tified in panel A. 
68  THE  ~OURNAL  OF  CELL  BIOLOGY  .  VOLUME  101,  1985 FIGURE 5  Specificity  of mAbs for identified domains of smooth muscle myosin heavy chain by Western  blot. Purified subunits 
of adult turkey gizzard myosin (1 #g/lane) were subjected  to SDS PAGE (panels A-D, 7.5% acrylamide; E-H,  12.5% acrylamide). 
Lanes: (a) HMM, (b) HMM produced by chymotryptic cleavage of myosin in the presence of ATP, (c) S-1, (d) LMM, (e) S-2, and 
(f)  mixed LC2o  and  LC~7. Panel E shows the Coomassie  Blue-stained gel;  B-D and  F-H are autoradiograms  of nitrocellulose 
replicas using mAbs TGM-1 (B and F), TGM-2 (C and G), or TGM-3 (D and H). The heavy chain of both 130-kD HMM and 97-kD 
S-1  undergo secondary proteolysis at a site ~70 kD from the amino-terminus (see Fig. 11). This gives rise to the additional bands 
seen below the main heavy chain bands in the HMM and S-1  preparations. (See reference 13 for a discussion of the digestion 
patterns.) 
FIGURE 6  mAb TGM-2 recognizes HMM, S-2 derived from either 
HMM or from rod, but not intact  rod.  (A-D)  HMM was digested 
with papain (0.01 U/mg HMM) and (E-H) rod with chymotrypsin (1 
mg/100 mg rod) at 25°C for the times shown.  Peptides (1 #g/lane) 
were separated by SDS PAGE (12.5% acrylamide).  A and  E show 
the Coomassie Blue-stained gel; B-D and F-H are autoradiograms 
of nitrocellulose replicas with mAbs TGM-1  (B and  F), TGM-2  (C 
and G), or TGM-3 (D and H). 
rod  (Fig.  6G).  Thus,  [125I-F(ab'h.TGM-2.S-2]  complexes 
were not formed when the S-2:LMM junction was intact, and 
we postulate that the TGM-2 binding site is at or near the S- 
2:LMM junction, mAb TMG-I (Fig. 6, B and F) and TGM- 
3 (Fig. 6, D and H) identified distinct families of proteolytic 
peptides derived only from HMM or from rod, respectively, 
and are shown for comparison. 
The globular S-1  head produced after digestion of myosin 
with  papain  retains  the  actin-binding  and  actin-activated 
Mg2÷-ATPase  activity of the  intact  myosin  molecule (29). 
Controlled proteolysis of skeletal  myosin  S-1  with  trypsin 
(30-32)  results  in  formation  of an  amino-terminal  25-kD 
adenine nucleotide-binding fragment, a  50-kD central frag- 
ment containing one of two actin cross-linking sites,  and a 
carboxy-terminal 20-kD fragment that  contains the second 
actin  cross-linking site,  the S-1:S-2 junction,  and  a  site  of 
probable association with myosin light chains (13,  33,  34). 
Smooth muscle  myosin S-I  similarly digested with  trypsin 
results in homologous fragments of  apparent molecular weight 
FIGURE 7  Identification of distinct  S-1  domains by 32P-LC20 and 
mAb TGM-1.  Gizzard myosin S-1 was digested with trypsin  (1  mg[ 
100 mg S-l) at 25°C for the times shown, and peptides (1 #g/lane) 
were resolved  by  SDS  PAGE (12.5%  acrylamide).  (A)  Coomassie 
Blue  stained gel; (B) autoradiogram after overlay with 32P-LC20  as 
described  in detail elsewhere (13); (C) autoradiogram of a nitrocel- 
lulose replica using mAb TGM-1. 
29-,  50-,  and  26-kD (references  13  and  35;  Fig.  7A).  The 
Western blot employing mAb TGM-I  localizes the TGM-1 
epitope (Fig. 7 C) to the 50-kD tryptic fragment; the antibody 
bound neither to the amino-terminal 29-kD fragment, nor to 
the carboxy-terminal 26-kD fragment that binds radiophos- 
phorylated 20-kD light chains of  gizzard myosin (see reference 
13 and Fig. 7 B). The 28-kD band detected in the immunoblot 
only at 7.5  and  30  min-digestion does not correspond with 
the 29-kD fragment, as shown in the 1.5-min lanes. 
After incubation of  gizzard HMM or S- 1 with rabbit skeletal 
muscle F-actin in the absence of ATP, such that all  actin- 
binding sites  were occupied, as determined by airfuge sedi- 
mentation of IS- 1. actin] complexes, little or no inhibition of 
mAb TGM-1 binding was detected (Fig.  8). Phosphorylated 
gizzard HMM  was  incubated with  mAb  TGM-I  and  then 
assayed for actin-activated Mg2+-ATPase activity. Little or no 
inhibition was detected under the conditions tested. In con- 
trast,  incubation of HMM with mAb TGM-2 resulted in a 
slight  increase  in  the  actin-activated Mg2+-ATPase  activity 
(see Table I). 
Topography of mAb Epitopes 
Fig.  9  shows  rotary-shadowed  specimens  of HMM  and 
HMM  reacted with TGM-1  and  TGM-2.  HMM  molecules 
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FIGURE 8  Binding of mAb directed against myosin S-1 and HMM 
in the presence and absence of actin. Turkey gizzard HMM (circles) 
or myosin  S-1  (squares) was incubated at 25°C for 30 min in the 
presence (solid symbols) or absence (open symbols) of rabbit skel- 
etal muscle F-actin, as previously described  (19). The proteins were 
immobilized on nitrocellulose for solid-phase  indirect radioimmu- 
noassay (see Materials and Methods) at the antigen concentration 
indicated. Results  shown are fmo112SI-F(ab')2  specifically bound per 
well. {A) Reaction of HMM and S-1  with TGM-1. (B) Reaction of 
HMM and S-1 with TGM-2. 
TABLE  I 
Actin-activated HMM ATPase in the Presence of mAbs Directed 
against HMM 
0.02*  0.05  O. 10 
Percentage of control of actin-activated 
mAb  MgATPase activity 
TGM-1  86  117  110 
TGM-2  192  171  185 
Phosphorylated  gizzard  HMM (0.02-0.1  p.M) was incubated at 37°C for 60 
rain with monoclonal IgG (0.33/~M) purified by DEAE-cellulo:se chromatog- 
raphy,  then assayed for actin-activated Mg2+-ATPase activity as previously 
described  (14). Pg-x63.Ag8  IgG  was used  as control.  The  control HMM 
ATPase activity was 0.35 p.mol Pi released/min per mg. 
* Values in heading  represent  p.M HMM. 
(Fig. 9 B) and [mAb- HMM] complexes (Fig. 9, C and D) were 
examined, and the topographic localization of  bound IgG was 
determined, mAb TGM-1  mapped specifically to S-l. Two 
forms of the [TGM-l. S-l] complex were detected (Fig. 9 C): 
one antibody attached to the lateral aspect of a  single  S-I 
head, or one antibody attached between the two S-1 heads of 
one HMM  molecule (intramolecular cross-linking).  Immu- 
noglobulin was present at approximately  twofold excess. How- 
ever, the proportion of nonreactive parental P3-X63.Ag8 IgG 
and hybrid molecules in the reaction mixture was not deter- 
mined.  Univalent [TGM- I. S- 1  ] complexes were essentially 
symmetric with  respect to the  long axis of the bound  S-l 
head, and thus were not analyzed for evidence of rotational 
freedom of the head as was detected using mAbs directed 
against the amino-terminal 25-kD fragment of  skeletal myosin 
S-I (9). 
mAb TGM-2, which in peptide binding studies bound S-2 
only in  the  absence  of an  intact  S-2:LMM junction,  was 
mapped specifically to S-2 and was further localized to the 
carboxy-terminus of S-2 (Fig.  8 D). The o-helical portion of 
HMM  did  not  extend beyond bound  antibody molecules. 
Thus, localization ofmAb TGM-I to S-I and TGM-2 to the 
carboxy-terminus  of  S-2, based on indirect radioimmunoassay 
and Western blot techniques, was substantiated by the topog- 
raphy of Individual [mAb.flMM] complexes determined by 
immunoelectron microscopy. 
FIGURE 9  Low-angle rotary shadowing  of [mAb. HMM] complexes 
with platinum. Gallery of individual unlabeled myosin (A) or HMM 
molecules (B) for reference.  (C) HMM molecules treated with anti- 
S-1  TGM-1,  labeled on the distal aspect of a single S-1  head, or 
labeled symmetrically between two  heads. (D)  HMM  molecules 
treated with anti-S-2 TGM-2, labeled at the carboxy-terminus of S- 
2. x 125,000. 
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TGM-1  32P-LC20  TGM-2  TGM-3 
FIGURE "10  Schematic  diagram  indicating  the  organization  of 
smooth muscle myosin  heavy chain domains.  Subunits generated 
after limited proteolysis with papain (P), yielding S-1  and  rod,  or 
with chymotrypsin (CT), yielding HMM and LMM, are labeled  above 
the figure.  T, principal sites of tryptic cleavage within S-1 and rod. 
Secondary sites of cleavage within S-1 by papain (P') or chymotryp- 
sin (CT') are also shown,  as well as an amino-terminal S-I  site of 
ATP-dependent  chymotryptic digestion (CT.,Tp). For clarity, only one 
heavy chain is illustrated, and subfragment lengths are not to scale. 
The topographic specificity of each  mAb  is  indicated below the 
figure; the 32P-LC20  binding site is labeled for comparison. 
DISCUSSION 
We have produced and characterized monoclonal antibodies 
that  label  epitopes distributed  among  three  distinct,  non- 
overlapping identified peptide domains of the 200-kD heavy 
chain of avian smooth muscle myosin. Though turkey gizzard 
myosin shares similar native structure and domain organiza- 
tion with myosin not only from mammalian smooth muscle 
but also from striated muscle, the antibodies reported here 
exhibit specificity for avian smooth muscle myosin alone and 
do  not  cross-react  with  purified  myosin  from  calf aorta, 
chicken pectoralis, or with avian nonmuscle myosin(s). Lo- 
calization of the smooth muscle myosin epitopes (Fig.  10) 
70  THE JOURNAL OF CELl. Blol.ocv - VOI.UME 101, 1985 was established by indirect radioimmunoassay employing pu- 
dried myosin subunits as well as by Western blot analysis of 
these subunits or of fragments generated by further proteoly- 
sis.  Assignment of mAb TGM-I  to S-1  and TGM-2  to the 
carboxy-terminus of S-2 based on peptide mapping is addi- 
tionally supported by the topography of [mAb. HMM] com- 
plexes visualized by electron microscopy after low-angle ro- 
tary shadowing with platinum. 
mAb TGM-1 recognizes a 50-kD tryptic peptide of S-1 but 
not the amino-terminal 20-kD fragment or carboxy-terminal 
26-kD LC2o-binding fragment. However, actin fails to inhibit 
TGM-1  binding,  and  conversely,  antibody  fails  to  inhibit 
actin-activated Mg2+-ATPase  of HMM.  Thus, we  have de- 
tected no functional interaction between  mAb TGM-1  and 
the actin-binding site within the 50-kD peptide. 
mAb TGM-2  recognizes an epitope of S-2 that is created 
by chymotryptic cleavage  of the S-2:LMM junction. Thus, 
TGM-2 recognizes HMM and S-2 but not intact myosin or 
myosin rod. Analogous results have been reported for poly- 
clonal antibodies produced in rabbits  immunized  with S-1 
derived from chicken pectoralis myosin that precipitate S-l 
but not intact myosin (36). We postulate, therefore, that the 
antibody-combining site  is located  at  or near the carboxy- 
terminus of S-2  and that [TGM-2.S-2]  complexes  are  not 
formed when the S-2:LMM junction is intact. This is con- 
firmed by immunoelectron microscopy. 
Evidence for myosin heavy chain polymorphism has been 
well established for a variety of vertebrate  striated muscles by 
biochemical (6, 37), immunologic (5, 9,  10),  and molecular 
genetic (8,  11,  12) investigations: synthesis of myosin heavy 
chains in both cardiac and skeletal  muscle is encoded and 
directed by a  multigene family (l l) resulting in the orderly 
sequential expression of a series  of myosin heavy chains. In 
contrast, the structural and functional properties of myosin 
in  developing  smooth  muscles  have  received  little  study. 
Katoh and Kubo identified a 23-kD myosin light chain of 9- 
d  embryonic chick gizzard, progressively replaced  by LC~7, 
but stated  that myosin  heavy chains  from  embryonic  and 
adult gizzard were immunologically identical by Ouchterlony 
immunodiffusion  and  quantitative  immunoprecipitation 
(38). In the present report mAb TGM-1, directed against an 
epitope of S-I  detected in the myosin heavy chain of adult 
turkey gizzard, bound poorly to the myosin heavy chain of 
embryonic chick smooth muscles. Thus, myosin heavy chains 
from embryonic and adult gizzard were found to be distinct; 
these results contradict the previous report  and indicate de- 
velopmental regulation of this site within the 50-kD tryptic 
peptide of S-I, whether by serial gene expression or by post- 
translational events (39). 
By employing low-angle platinum shadowing, we have lo- 
calized the 50-kD tryptic peptide of S-l, which occupies the 
mid-portion of the S-1  linear amino  acid  sequence,  to the 
distal  aspect  of the  myosin  head.  This  finding  should  be 
considered in the context of previous reports that mAbs that 
map to the amino-terminal fragment of S- 1 localize to either 
the upper or lower surface  of the head (9) and is consistent 
with the proposal by Morner et at. (30) regarding the skewed 
distribution  of mass  in  rabbit  skeletal  myosin  S-1.  These 
observations thus provide  the  first  direct  evidence  for the 
topographic organization of the myosin heavy chain within 
the smooth muscle myosin head and furnish additional evi- 
dence that homologous structural  organization of domains is 
conserved even in the presence of significant antigenic diver- 
sity among myosins of disparate origin. 
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